Best Nuclear & Uranium Stocks to Watch in 2026

Nuclear and uranium stocks are experiencing a historic bull run in 2026 as the sector benefits from a perfect storm of catalysts. The global uranium market, valued at $9.7 billion in 2025, is projected to grow to $13.6 billion by 2033, driven by AI data center power demands, grid reliability concerns, and decades of underinvestment in uranium supply. With spot uranium prices surging past $100 per pound in early 2026 and structural supply deficits widening, investors are scrambling to gain exposure to this critical energy transition theme.

This guide examines the best nuclear and uranium stocks to watch now, focusing on growth compounders rather than legacy dividend plays. We analyze established leaders, mid-cap growth names, and emerging disruptors positioned to benefit from the nuclear energy renaissance.

Key Takeaways

• Uranium prices hit $100/lb in January 2026, marking a 25% surge and signaling a new bullish phase driven by supply constraints and rising nuclear demand
• Revenue growth rates of 27-48% are forecast for leading uranium producers like Energy Fuels and Uranium Energy Corp over the next three years
• HALEU (High-Assay Low-Enriched Uranium) represents a major growth catalyst for enrichment companies, with Centrus Energy holding a $900 million DOE task order
• The nuclear sector offers diversified exposure across miners, enrichers, and SMR developers, each with distinct risk-reward profiles

Like these picks? Our premium members get our actual portfolio holdings, entry prices, and real-time portfolio update alerts before anyone else. See Premium →

Nuclear & Uranium Stocks Summary Table

---

Cameco Corporation (CCJ)

Outlook: Bullish | Risk: 2/5 | Conviction: High

Analyst target implies: +55% from current price

Cameco remains the dominant force in global uranium production and the safest way to play the nuclear renaissance. As the world's largest publicly traded uranium company, Cameco offers vertically integrated exposure across mining, conversion, and fuel services.

Growth Catalysts

The company's earnings trajectory is exceptional. The Zacks Consensus Estimate projects 96% year-over-year earnings growth for fiscal 2025, followed by another 55% growth in fiscal 2026. This acceleration reflects higher contract prices as utilities rush to secure long-term supply amid geopolitical tensions.

Cameco recently signed a landmark $2.6 billion uranium supply agreement with India's Department of Atomic Energy, covering nearly 22 million pounds over nine years. India currently operates 24 reactors with ambitious plans to deploy dozens more to reach 100 GW by 2047.

The company also increased its ownership stake in the Cigar Lake mine, described by CEO Tim Gitzel as "among the world's best uranium mines, producing the highest-grade uranium ore from a safe, reliable, and cost-effective operation."

Valuation & Risk

At $100.96 per share with a $44 billion market cap, Cameco trades at an elevated P/E of 92.5x. However, this reflects growth expectations as the company benefits from a tight uranium market. Cameco stock has gained 26.7% over the past six months and currently carries a Zacks Rank #3 (Hold).

The primary risk is commodity price volatility. Management cut parts of 2025 production guidance due to McArthur River delays, signaling that supply responses may be lumpy. For investors seeking stable exposure to nuclear energy's growth, Cameco remains the benchmark choice.

---

Energy Fuels Inc. (UUUU)

Outlook: Bullish | Risk: 3/5 | Conviction: High

Analyst target implies: +70% from current price

Energy Fuels has transformed from a pure uranium play into a diversified critical minerals platform, making it uniquely positioned for multiple growth catalysts.

Growth Catalysts

Q1 2026 revenue hit $35.8 million, smashing the $31.3 million Street estimate and more than doubling from a year earlier. While the company still posted a net loss of $10.9 million ($0.04 per share), this represents a significant improvement from the prior year's $0.13 loss.

Energy Fuels is the only uranium stock providing simultaneous exposure to rare earth elements, a critical mineral category with independent demand growth tied to electric vehicles, wind turbines, and advanced defense technology. The company operates the only active conventional uranium mill in the United States.

For 2026, management expects to produce 1.5 to 2.5 million pounds of finished U3O8, with approximately 1.6 million pounds expected by mid-year. Revenue is forecast to grow 27-48% annually over the next three years, dramatically outpacing the 3.5% growth forecast for the broader oil and gas industry.

Valuation & Risk

At $15.34 with a $4.3 billion market cap, UUUU has surged 401% over the past year, sharply outperforming the industry's 88.2% growth. The balance sheet is pristine: roughly $910.7 million in cash and short-term investments with no debt, providing a long runway for expansion.

Analyst targets range from $17 (Roth Capital) to $29 (H.C. Wainwright), with Goldman Sachs maintaining a Buy rating despite lowering its target to $21. The 12-month consensus target of $25.60 implies 63.7% upside from current levels.

---

Centrus Energy Corp. (LEU)

Outlook: Bullish | Risk: 3/5 | Conviction: Medium-High

Analyst target implies: +50% from current price

Centrus Energy occupies a strategically critical position as the only U.S.-based commercial uranium enrichment company, giving it an irreplaceable role in America's efforts to build a domestic nuclear fuel supply chain.

Growth Catalysts

The company's Technical Solutions segment is the primary growth driver, with revenue surging 47% in Q1 2026 as HALEU development activity accelerated. HALEU (High-Assay Low-Enriched Uranium) is the fuel specification required by virtually all advanced reactor designs and SMR concepts currently in development.

Centrus holds a $900 million HALEU-related task order from the U.S. Department of Energy. Without reliable domestic HALEU supply, the U.S. advanced nuclear program faces a fundamental bottleneck regardless of how many reactor designs receive regulatory approval.

For Q1 2026, Centrus reported revenue of $76.7 million with adjusted diluted EPS of $1.05, well above analyst expectations. The company raised its full-year revenue forecast to $450-500 million and reported approximately $1.87 billion in cash.

Valuation & Risk

LEU shares recently traded around $162, significantly below the 52-week high of $464.25. This elevated volatility reflects the policy-dependent nature of parts of the business and sentiment swings around government contracting timelines.

Analyst targets range from $137 to $315, with Roth Capital raising its target to $230 and Citi at $218. The stock carries a consensus Hold rating with 36% Strong Buy recommendations. For investors comfortable with government contract exposure, Centrus offers unique leverage to the advanced nuclear buildout.

---

Uranium Energy Corp. (UEC)

Outlook: Watch | Risk: 4/5 | Conviction: Medium

Analyst target implies: +40% from current price

Uranium Energy Corp. is advancing as the largest and fastest-growing uranium supplier in the United States, but recent earnings volatility warrants caution.

Growth Catalysts

UEC is positioned as the only U.S. integrated uranium supplier following the launch of its UR&C platform. The company operates low-cost in-situ recovery (ISR) uranium mining projects across Wyoming and Texas, offering advantages including lower capital costs, faster timelines, and reduced environmental impact.

Revenue is forecast to grow 37% annually on average over the next three years, compared to just 3.3% growth for the broader oil and gas industry. The company has strengthened its balance sheet with $698 million in liquidity and no debt.

UEC recently commenced production at its Burke Hollow project, the world's newest ISR uranium mine and the first new U.S. uranium project in years.

Valuation & Risk

The stock experienced significant volatility following Q3 fiscal 2026 results. UEC reported a net loss of $0.11 per share, nearly four times the $0.03 loss analysts expected. Shares dropped approximately 23% in two days following the earnings miss.

At $11.68 with a market cap of approximately $5.8 billion, UEC trades below its 52-week high of $20.34. Goldman Sachs lowered its price target to $16 from $18 but maintains a Buy rating. The average 12-month target of $19.17 implies 64% upside, but execution risk remains elevated. This is a watch-and-accumulate-on-weakness situation.

---

NuScale Power Corporation (SMR)

Profile: SPECULATIVE — HIGH RISK | Risk: 5/5 | Conviction: Low

Analyst target implies: +110% from current price

NuScale Power represents a high-risk, high-reward bet on the small modular reactor revolution. The company holds the sole U.S. NRC design certification for SMR technology.

Growth Catalysts

NuScale is pushing a planned U.S. nuclear buildout of up to 6 GW through ENTRA1/TVA partnerships while advancing Romania's RoPower project. Japan recently pledged $25 billion toward U.S. small modular reactor projects, sending SMR shares surging over 5% in overnight trading.

The company maintains strong liquidity of approximately $1 billion, sufficient to fund operations through 2026-2027. Management discussed the potential for positive operational cash flow in 2026-2027 during recent earnings calls.

NuScale added experienced directors Stuart Harshaw and former NRC chair Dale Klein to its board, signaling commitment to execution.

Valuation & Risk

SMR shares have faced significant declines, down nearly 40% year-to-date. The stock trades at $10.02 with a market cap of $3.5 billion. Bank of America reinstated coverage with a Neutral rating and $12 price target, stressing that meaningful reactor revenue will likely arrive only in the early 2030s.

Analyst targets range from $9 (Goldman Sachs) to $60, with a median of $21. The 52-week range spans from $8.85 to $57.42, illustrating extreme volatility. This is purely a speculative position for investors with long time horizons and high risk tolerance.

---

Navigating Nuclear & Uranium Stocks

Direct Stock Purchases

For concentrated exposure, consider building a diversified portfolio across the nuclear value chain:

• Miners (CCJ, UUUU, UEC): Direct leverage to uranium prices
• Enrichment (LEU): Critical fuel cycle infrastructure
• Technology (SMR): Next-generation reactor development

ETF Options

For broader exposure with reduced single-stock risk:

• URA (Global X Uranium ETF): Mining-focused, surged over 25% in January 2026
• URNM (Sprott Uranium Miners ETF): Pure-play uranium miners
• NLR (VanEck Uranium+Nuclear Energy ETF): Diversified nuclear exposure

Position Sizing Considerations

Given the sector's volatility, consider:

• Staggered entry points to average into positions
• Limiting nuclear exposure to 5-10% of total portfolio
• Balancing established producers (CCJ) with growth names (UUUU, LEU)
• Treating SMR positions as venture-style allocations

---

The Bull Case for Uranium in 2026

The uranium market is experiencing a structural re-rating driven by multiple converging factors:

Supply Constraints: U.S. domestic production still falls far short of the 50+ million pounds consumed annually, leaving utilities dependent on imports. Urenco announced plans to increase enrichment capacity at its U.S. facility by nearly 50% in June 2026, signaling confidence in long-term nuclear growth.

AI-Driven Demand: The hard economic logic of AI infrastructure and grid reliability is driving nuclear power's renaissance. Tech-sector nuclear power purchase agreements represent a key catalyst to monitor.

Policy Support: The U.S. government's Section 232 framework explicitly designates uranium as vital for energy security and national defense, placing it alongside rare earths and lithium as a strategic resource.

Institutional Accumulation: Funds that accumulate physical uranium create additional demand beyond traditional utilities, removing supply from the spot market and strengthening the long-term bull thesis.

---

Conclusion

The nuclear and uranium sector offers compelling growth opportunities for investors willing to accept volatility. Cameco provides the safest large-cap exposure, while Energy Fuels and Centrus Energy offer mid-cap growth with differentiated business models. Uranium Energy Corp. warrants monitoring after its recent earnings stumble, and NuScale Power remains a speculative bet on SMR commercialization.

The uranium trade is not a quick flip. It is a multi-year thesis built on structural demand growth meeting constrained supply. For patient investors who position early, the nuclear renaissance may deliver significant returns as governments and industries increasingly rely on nuclear power to meet long-term energy and climate objectives.

---

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor before making investment decisions.